Your browser doesn't support javascript.
loading
Fasting-sensitive SUMO-switch on Prox1 controls hepatic cholesterol metabolism.
Alfaro, Ana Jimena; Dittner, Claudia; Becker, Janina; Loft, Anne; Mhamane, Amit; Maida, Adriano; Georgiadi, Anastasia; Tsokanos, Foivos-Filippos; Klepac, Katarina; Molocea, Claudia-Eveline; El-Merahbi, Rabih; Motzler, Karsten; Geppert, Julia; Karikari, Rhoda Anane; Szendrödi, Julia; Feuchtinger, Annette; Hofmann, Susanna; Karaca, Samir; Urlaub, Henning; Berriel Diaz, Mauricio; Melchior, Frauke; Herzig, Stephan.
Afiliação
  • Alfaro AJ; Institute for Diabetes and Cancer, Helmholtz Munich, Neuherberg, Germany.
  • Dittner C; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.
  • Becker J; German Center for Diabetes Research (DZD), and German Center for Cardiovascular Disease (DZHK), Neuherberg, Germany.
  • Loft A; Zentrum für Molekulare Biologie der Universität Heidelberg (ZMBH), Heidelberg University, DKFZ-ZMBH Alliance, Heidelberg, Germany.
  • Mhamane A; Zentrum für Molekulare Biologie der Universität Heidelberg (ZMBH), Heidelberg University, DKFZ-ZMBH Alliance, Heidelberg, Germany.
  • Maida A; Institute for Diabetes and Cancer, Helmholtz Munich, Neuherberg, Germany.
  • Georgiadi A; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.
  • Tsokanos FF; German Center for Diabetes Research (DZD), and German Center for Cardiovascular Disease (DZHK), Neuherberg, Germany.
  • Klepac K; Center for Functional Genomics and Tissue Plasticity (ATLAS), SDU, Odense, Denmark.
  • Molocea CE; Institute for Diabetes and Cancer, Helmholtz Munich, Neuherberg, Germany.
  • El-Merahbi R; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.
  • Motzler K; German Center for Diabetes Research (DZD), and German Center for Cardiovascular Disease (DZHK), Neuherberg, Germany.
  • Geppert J; Institute for Diabetes and Cancer, Helmholtz Munich, Neuherberg, Germany.
  • Karikari RA; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.
  • Szendrödi J; German Center for Diabetes Research (DZD), and German Center for Cardiovascular Disease (DZHK), Neuherberg, Germany.
  • Feuchtinger A; Institute for Diabetes and Cancer, Helmholtz Munich, Neuherberg, Germany.
  • Hofmann S; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.
  • Karaca S; German Center for Diabetes Research (DZD), and German Center for Cardiovascular Disease (DZHK), Neuherberg, Germany.
  • Urlaub H; Institute for Diabetes and Cancer, Helmholtz Munich, Neuherberg, Germany.
  • Berriel Diaz M; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.
  • Melchior F; German Center for Diabetes Research (DZD), and German Center for Cardiovascular Disease (DZHK), Neuherberg, Germany.
  • Herzig S; Institute for Diabetes and Cancer, Helmholtz Munich, Neuherberg, Germany.
EMBO Rep ; 24(10): e55981, 2023 Oct 09.
Article em En | MEDLINE | ID: mdl-37560809
ABSTRACT
Accumulation of excess nutrients hampers proper liver function and is linked to nonalcoholic fatty liver disease (NAFLD) in obesity. However, the signals responsible for an impaired adaptation of hepatocytes to obesogenic dietary cues remain still largely unknown. Post-translational modification by the small ubiquitin-like modifier (SUMO) allows for a dynamic regulation of numerous processes including transcriptional reprogramming. We demonstrate that specific SUMOylation of transcription factor Prox1 represents a nutrient-sensitive determinant of hepatic fasting metabolism. Prox1 is highly SUMOylated on lysine 556 in the liver of ad libitum and refed mice, while this modification is abolished upon fasting. In the context of diet-induced obesity, Prox1 SUMOylation becomes less sensitive to fasting cues. The hepatocyte-selective knock-in of a SUMOylation-deficient Prox1 mutant into mice fed a high-fat/high-fructose diet leads to a reduction of systemic cholesterol levels, associated with the induction of liver bile acid detoxifying pathways during fasting. The generation of tools to maintain the nutrient-sensitive SUMO-switch on Prox1 may thus contribute to the development of "fasting-based" approaches for the preservation of metabolic health.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article